fda warning letter glp-1 october 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA AI Warning Letter (Purolea):

For a deep dive on retatrutide, see: What Is Retatrutide

But mechanism alone does not prove a clinical outcome

is a co-founder of Sensory Cloud

Choosing the Right GLP-1 Medication for Your Goals Selecting between semaglutide, tirzepatide, and other GLP-1 options requires consideration of several factors: desired weight loss magnitude, injection frequency preference, side-effect tolerance, budget, and individual genetic predispositions

Support for Aging and Longevity As levels decline with age, supplementation may help mitigate age-related health issues by reducing oxidative stress and supporting cellular health

For the best results on your weight loss journey, look no further than The Everything Guide to GLP-1s